The efficacy of testosterone ointment (Glowmin) treatment for late-onset-hypogonadism (LOH) patients according to LOH severity

Acta Urologica Japonica

Volumn 53, Issue 1, 2007, Pages 25-29

  Amano, Toshiyasu ^a   Imao, Tetsuya ^a   Takemae, Katsurou ^a   Iwamoto, Teruaki ^b   Baba, Katsuyuki ^b   Yamakawa, Katsunori ^b   Nakazawa, Ryuto ^b   Yoshida, Katsumi ^b   Sugimori, Hiroki ^b   Tanaka, Toshiaki ^b   Katabami, Takuyuki ^b   Tanaka, Masami ^b  

^a NAGANO RED CROSS HOSPITAL   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Late onset hypogonadism; LOH severity; Testosterone ointment

Indexed keywords

TESTOSTERONE;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; DRUG EFFECT; HOSPITALIZATION; HUMAN; HYPOGONADISM; MALE; MIDDLE AGED; OINTMENT; PENIS ERECTION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; OINTMENTS; PENILE ERECTION; SEVERITY OF ILLNESS INDEX; TESTOSTERONE;

EID: 33847200068     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Juul A and Skakkebaek NE : Androgens and the aging. Hum Reprod Update 7 : 423-433, 2002
2. Nakazawa R, Baba K, Nakano M, et al. : Hormone profiles after the intramuscular injection of testosterone enanthate in patients with hypogonadism. Endocrine J (in press), 2006
3. Japanese source
4. Heinemann LAJ, Zimmermann T, Vermeulen A, et al. : A new "aging males' symptoms" rating scale. Aging Male 2 : 105-114, 1999
5. Rosen RC, Cappelleri JC, Smith MD, et al. : Development and evaluation of an abridged, 5-item version of the international index of erectile function (IIEF5) as a diagnostic tool for erectile function. Int J Impot Res 11 : 319-326, 1999
6. Japanese source
7. Japanese source
8. Japanese source
9. Japanese source
10. Japanese source
11. Morales A and Tenover JL : Androgen deficiency in the aging male: when, who, and how to investigate and treat. Urol Clin North Am 29 : 975-982, 2002
12. Japanese source
13. Mod Physician 24 : 283-287, 2004
14. Japanese source
15. Kirby R and Gould D : Testosterone replacement therapy in hypogonadal men and prostate cancer risk. BJU Int 96 : 471-472, 2005
16. El-Sakka AI, Hassoba HM, Elbakry AM, et al. : Prostatic specific antigen in patients with hypogonadism: effect of testosterone replacement. J Sex Med 2 : 235-240, 2005
17. Rhoden EL and Morgentaler A : Risk of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med 350 : 482-492, 2004
18. Gaylis FD, Lin DW, Ignatoff JM, et al. : Prostate cancer in men using testosterone supplementation. J Urol 174 : 534-538, 2005
19. Sengupta S, Duncan HJ, Macgregor RJ, et al. : The development of prostate cancer despite late onset androgen deficiency. Int J Urol 12 : 847-848, 2005